BioCentury | Aug 17, 2019
Financial News

Aug. 16 Financial Quick Takes: Trio of IPO filings; plus Bellicum, Generex

...million. The offering is expected to close Aug. 21. Generex to spin out immuno-oncology business Generex Biotechnology Corp....
...The newco will also contain Kiromic Inc., which Generex announced plans to acquire in June. Generex...
...ownership stake up to 99%. Val Kennedy, Associate Editor and Elizabeth S. Eaton, Staff Writer Bellicum Pharmaceuticals Inc. Generex Biotechnology Corp. Monopar...
BioCentury | Feb 16, 2019
Company News

Management tracks: Nimbus, Ascentage, Cadent, Skyhawk

...of LFB S.A. (Les Ulis, France). Generex Biotechnology Corp. (Pink:GNBT) hired Marshal Schictman as EVP, general counsel. Generex...
BioCentury | Jan 12, 2018
Company News

Generex grants Shenzhen rights in China to cancer vaccine

...Antigen Express Inc., a subsidiary of Generex Biotechnology Corp. (OTCQB:GNBT), granted Shenzhen BioScien Pharmaceuticals Co. Ltd. (Shenzhen, China...
...Macau, to treat prostate cancer. Generex received an upfront payment of $700,000 from Shenzhen BioScien. Generex...
...protein fragment. Generex Biotechnology Corp. (OTCQB:GNBT), Miramar, Fla. Shenzhen BioScien Pharmaceuticals Co. Ltd., Shenzhen, China Business: Cancer Jennie Walters AE37 Generex Biotechnology Corp. Epidermal...
BioCentury | Mar 31, 2017
Financial News

Generex completes private placement of convertible preferred stock

...On March 29, drug delivery company Generex Biotechnology Corp. (Pink:GNBTD) raised $3 million through the sale of 3,000...
...in the first tranche of a planned $115 million private placement with an institutional investor. Generex...
...tranches consist of series H stock; both initially convert at $2.50. Generex Biotechnology Corp. (Pink:GNBTD), Miramar, Fla. Alex Himes Generex Biotechnology Corp....
BioCentury | Oct 12, 2015
Company News

Generex, CannScience deal

...Generex and CannScience partnered to co-develop buccally delivered cannabinoid-derived products. Generex granted CannScience exclusive rights to...
...commercialize a dose-specific, buccally delivered product in 12-18 months. Generex did not respond to inquiries. Generex Biotechnology Corp....
BioCentury | Mar 31, 2014
Financial News

Generex completes private placement of units

Generex Biotechnology Corp. (OTCBB:GNBT), Toronto, Ontario Business: Drug delivery Date completed: 3/27/14 Type: Private placement of units Raised: $2.1 million Units: 2,075 Price: $1,000 (unit) Shares outstanding prior: 730.5 million Investors: Institutional investors Note: Each...
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...to commercialize Taxus Cardium's products, including wound care product Excellagen and cardiovascular gene therapy product Generex...
...Taxus Cardium reported $109,200 in Excellagen sales for the nine months ended Sept. 30, 2013. Generex...
BioCentury | Jan 27, 2014
Clinical News

Ii-Key/HER2/neu cancer vaccine: Completed Phase II enrollment

...Phase II trial evaluating 6 monthly intradermal inoculations of AE37 adjuvanted with GM-CSF. In 2011, Generex...
...a median follow-up of 13 months (see BioCentury, June 21, 2010 & Jan. 31, 2011). Generex Biotechnology Corp....
BioCentury | Sep 2, 2013
Clinical News

Ii-Key/HER2/neu cancer vaccine: Phase I data

...0% of intermediate- (n=9) and high-risk (n=8) patients as determined by Gleason score developed metastasis. Generex...
...OS) of 89 months. AE37 was well tolerated. Data were published in Cancer Immunology, Immunotherapy. Generex...
...year from a Phase II trial for AE37 to prevent relapse in breast cancer patients. Generex Biotechnology Corp....
BioCentury | Jul 15, 2013
Clinical News

Generex Oral-lyn: Phase III data

...12 (0.45% vs. 0.23%). Generex Oral-lyn was well tolerated. The trial was conducted by Shreya. Generex...
...I and II diabetes by year end. According to Generex, regulatory authorities in India approved Generex...
...treat diabetes. Generex Biotechnology Corp. (OTCBB:GNBT), Toronto, Ontario Shreya Life Sciences Pvt. Ltd. , Mumbai, India Product: Generex...
Items per page:
1 - 10 of 188
BioCentury | Aug 17, 2019
Financial News

Aug. 16 Financial Quick Takes: Trio of IPO filings; plus Bellicum, Generex

...million. The offering is expected to close Aug. 21. Generex to spin out immuno-oncology business Generex Biotechnology Corp....
...The newco will also contain Kiromic Inc., which Generex announced plans to acquire in June. Generex...
...ownership stake up to 99%. Val Kennedy, Associate Editor and Elizabeth S. Eaton, Staff Writer Bellicum Pharmaceuticals Inc. Generex Biotechnology Corp. Monopar...
BioCentury | Feb 16, 2019
Company News

Management tracks: Nimbus, Ascentage, Cadent, Skyhawk

...of LFB S.A. (Les Ulis, France). Generex Biotechnology Corp. (Pink:GNBT) hired Marshal Schictman as EVP, general counsel. Generex...
BioCentury | Jan 12, 2018
Company News

Generex grants Shenzhen rights in China to cancer vaccine

...Antigen Express Inc., a subsidiary of Generex Biotechnology Corp. (OTCQB:GNBT), granted Shenzhen BioScien Pharmaceuticals Co. Ltd. (Shenzhen, China...
...Macau, to treat prostate cancer. Generex received an upfront payment of $700,000 from Shenzhen BioScien. Generex...
...protein fragment. Generex Biotechnology Corp. (OTCQB:GNBT), Miramar, Fla. Shenzhen BioScien Pharmaceuticals Co. Ltd., Shenzhen, China Business: Cancer Jennie Walters AE37 Generex Biotechnology Corp. Epidermal...
BioCentury | Mar 31, 2017
Financial News

Generex completes private placement of convertible preferred stock

...On March 29, drug delivery company Generex Biotechnology Corp. (Pink:GNBTD) raised $3 million through the sale of 3,000...
...in the first tranche of a planned $115 million private placement with an institutional investor. Generex...
...tranches consist of series H stock; both initially convert at $2.50. Generex Biotechnology Corp. (Pink:GNBTD), Miramar, Fla. Alex Himes Generex Biotechnology Corp....
BioCentury | Oct 12, 2015
Company News

Generex, CannScience deal

...Generex and CannScience partnered to co-develop buccally delivered cannabinoid-derived products. Generex granted CannScience exclusive rights to...
...commercialize a dose-specific, buccally delivered product in 12-18 months. Generex did not respond to inquiries. Generex Biotechnology Corp....
BioCentury | Mar 31, 2014
Financial News

Generex completes private placement of units

Generex Biotechnology Corp. (OTCBB:GNBT), Toronto, Ontario Business: Drug delivery Date completed: 3/27/14 Type: Private placement of units Raised: $2.1 million Units: 2,075 Price: $1,000 (unit) Shares outstanding prior: 730.5 million Investors: Institutional investors Note: Each...
BioCentury | Mar 24, 2014
Company News

Shanxi Taxus, Taxus Cardium deal

...to commercialize Taxus Cardium's products, including wound care product Excellagen and cardiovascular gene therapy product Generex...
...Taxus Cardium reported $109,200 in Excellagen sales for the nine months ended Sept. 30, 2013. Generex...
BioCentury | Jan 27, 2014
Clinical News

Ii-Key/HER2/neu cancer vaccine: Completed Phase II enrollment

...Phase II trial evaluating 6 monthly intradermal inoculations of AE37 adjuvanted with GM-CSF. In 2011, Generex...
...a median follow-up of 13 months (see BioCentury, June 21, 2010 & Jan. 31, 2011). Generex Biotechnology Corp....
BioCentury | Sep 2, 2013
Clinical News

Ii-Key/HER2/neu cancer vaccine: Phase I data

...0% of intermediate- (n=9) and high-risk (n=8) patients as determined by Gleason score developed metastasis. Generex...
...OS) of 89 months. AE37 was well tolerated. Data were published in Cancer Immunology, Immunotherapy. Generex...
...year from a Phase II trial for AE37 to prevent relapse in breast cancer patients. Generex Biotechnology Corp....
BioCentury | Jul 15, 2013
Clinical News

Generex Oral-lyn: Phase III data

...12 (0.45% vs. 0.23%). Generex Oral-lyn was well tolerated. The trial was conducted by Shreya. Generex...
...I and II diabetes by year end. According to Generex, regulatory authorities in India approved Generex...
...treat diabetes. Generex Biotechnology Corp. (OTCBB:GNBT), Toronto, Ontario Shreya Life Sciences Pvt. Ltd. , Mumbai, India Product: Generex...
Items per page:
1 - 10 of 188